Format

Send to

Choose Destination

Treatment of vulvovaginal candidiasis: a review of the literature.

Author information

1
University Clinical Department of Gynecology and Perinatology, Maribor University Clinical Centre, Maribor, Slovenia. Corresponding author: andrazdovnik@gmail.com.
2
Department of Medical Microbiology, Medical Microbiology Center, National Laboratory of Health, Environment, and Food, Maribor, Slovenia.
3
University Clinical Department of Gynecology and Perinatology, Maribor University Clinical Centre, Maribor, Slovenia.
4
University Clinical Department of Gynecology and Perinatology, Maribor University Clinical Centre, Maribor, Slovenia. Department of Gynecology and Perinatology, University of Maribor Faculty of Medicine, Maribor, Slovenia.

Abstract

Vulvovaginal candidiasis (VVC) affects around three-quarters of all women during their reproductive age, although the exact incidence of VVC is difficult to determine because many patients are self-treated. The infections are divided into complicated and uncomplicated. Uncomplicated VVC is most effectively treated with local azoles. Oral treatment with a single dose of fluconazole is also effective for treating uncomplicated VVC. Treatment of complicated VVC is prolonged and most commonly consists of multiple doses of oral fluconazole or at least 1 week of local azoles. The role of probiotics in treating VVC is still disputed. This article presents a review of the literature on the various treatment options for VVC. Treatment for the most common pathogens that cause complicated VVC is also discussed.

PMID:
25770305
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Slovenian Dermatovenerological Society
Loading ...
Support Center